These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3487646)

  • 1. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-penicillamine induced lupus during the treatment of rheumatoid arthritis. Report of 2 cases and systematic immunologic study during the treatment].
    Crouzet J; Camus JP; Leca AP; Guillien P; Lièvre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):71-9. PubMed ID: 4136184
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are antinuclear factors a contraindication for penicillamine treatment in patients with rheumatoid arthritis? (author's transl)].
    Scherak O; Hiesberger H; Kolarz G
    Wien Klin Wochenschr; 1978 Feb; 90(3):95-6. PubMed ID: 304637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interactions between rheumatoid factors and antinuclear autoantibodies: their occurrence in a concealed state in rheumatoid disease (arthritis); effect of D-penicillamine].
    Mach PS; Delbarre F; Piatier D
    C R Seances Acad Sci D; 1980 Feb; 290(8):575-8. PubMed ID: 6767559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine toxicity in Greek patients with rheumatoid arthritis: anti-Ro(SSA) antibodies and cryoglobulinemia are predictive factors.
    Vlachoyiannopoulos PG; Zerva LV; Skopouli FN; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1991 Jan; 18(1):44-9. PubMed ID: 1827158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results?
    Menard HA; Mathieu JP; de Medicis R; Lussier A
    J Rheumatol; 1979; 6(2):156-62. PubMed ID: 110929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies].
    Masson CJ; Ménard HA; Audran M; Renier JC; Lussier A; Myhal DM
    Union Med Can; 1986 Dec; 115(12):855-9. PubMed ID: 3492802
    [No Abstract]   [Full Text] [Related]  

  • 9. Penicillamine-induced lupus-like reaction in rheumatoid arthritis and vasculitis.
    Thorvaldsen J
    Dermatologica; 1981; 162(4):277-80. PubMed ID: 6455314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A chemically induced polyneuropathy in chronic polyarthritis treated with D-penicillamine?].
    Mayr N; Graninger W; Wessely P
    Wien Klin Wochenschr; 1983 Feb; 95(3):86-8. PubMed ID: 6305039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-histone antibodies in rheumatoid arthritis].
    Youinou P; Brousse A; Le Goff P
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):419-20. PubMed ID: 6333712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autoimmune phenomena in D-penicillamine therapy].
    Kolarz G; Ludwig H; Sabeti M; Scherak O
    Acta Med Austriaca; 1975; 2(4):130-3. PubMed ID: 1083615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between IgM antiglobulins and IgG antinuclear antibodies. Some aspects of D-penicillamine activities.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1979 May; 36(2):311-6. PubMed ID: 383333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical application of an ELISA technique for the detection of antihistone antibodies.
    Epstein A; Greenberg M; Halbert S; Kramer L; Barland P
    J Rheumatol; 1986 Apr; 13(2):304-7. PubMed ID: 3522897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus-like syndromes induced by drugs.
    Harpey JP
    Ann Allergy; 1974 Nov; 33(5):256-61. PubMed ID: 4138815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.